The cancer types commonly considered important for risk assessment are breast (female and male), ovarian, prostate, and pancreatic cancer, all of which are included in the BOADICEA model predicting risk of cancer for BRCA1 and BRCA2 pathogenic variant carriers (Antoniou et al., 2008). This evidence concerns the gene BRCA1 and cancer.